RaQualia Ties Up with Intracellular Antibody Upstart on Drug Discovery

August 17, 2022
RaQualia Pharma said on August 15 that it has entered into a capital and business alliance with Tokyo-based startup Stand Therapeutics with the aim of discovering treatments for intractable and rare diseases using intracellular antibodies - or antibodies that work...read more